User: Guest  Login
Title:

Acute side effects after consumption of the new synthetic cannabinoids AB-CHMINACA and MDMB-CHMICA.

Document type:
Journal Article
Author(s):
Hermanns-Clausen, Maren; Müller, Dieter; Kithinji, Josephine; Angerer, Verena; Franz, Florian; Eyer, Florian; Neurath, Hartmud; Liebetrau, Gesine; Auwärter, Volker
Abstract:
In 2014, the "European Monitoring Centre for Drugs and Drug Addiction" (EMCDDA) reported on 30 novel synthetic cannabinoids (SCs). Among these were indole- and indazole-based valine derivatives with a cyclohexylmethyl side chain (e.g., AB-CHMINACA and MDMB-CHMICA), which represent a new class of SCs.A prospective observational study of patients treated in emergency departments (EDs) after the intake of SCs was conducted. Clinical and laboratory data were combined and reported to a poison control...     »
Journal title abbreviation:
Clin Toxicol (Phila)
Year:
2018
Journal volume:
56
Journal issue:
6
Pages contribution:
404-411
Language:
eng
Fulltext / DOI:
doi:10.1080/15563650.2017.1393082
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/29072524
Print-ISSN:
1556-3650
TUM Institution:
2. Medizinische Klinik Toxikologische Abteilung (alt) (Prof. Zilker)
 BibTeX